Erratum: Selective adhesion of nanoparticles to inflamed tissue in gastric ulcers (Pharmaceutical Research (2009) DOI: 10.1007/s11095-009-9834-1));Selective adhesion of nanoparticles to inflamed tissue in gastric ulcers

Pharmaceutical Research

Volumn 26, Issue 5, 2009, Pages 1149-1154

  Hasani, Saad ^a   Pellequer, Yann ^a   Lamprecht, Alf ^a,b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Bioadhesion; Drug targeting; Gastric epithelium; Gastric ulcer; Nanoparticles

Indexed keywords

NANOPARTICLE; POLYSTYRENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HELICOBACTER INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH EPITHELIUM; STOMACH ULCER; SWISS WEBSTER MOUSE;

EID: 63949084469     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9872-8     Document Type: Erratum

References (24)

1. J. E. Crabtree 1996 Immune and inflammatory responses to Helicobacter pylori infection Scand. J. Gastroenterol. Suppl. 215 3 10 doi:10.3109/ 00365529609094526
2. P. Correa 1995 Helicobacter pylori and gastric carcinogenesis Am. J. Surg. Pathol. 19 Suppl 1 S37 S43
3. Y. Tabata Y. Ikada 1990 Phagocytosis of polymer microspheres by macrophages Adv. Polym. Sci. 94 107 141 doi:10.1007/BFb0043062
4. A. Lamprecht U. Schäfer C. M. Lehr 2001 Size dependent targeting of micro- and nanoparticulate carriers to the inflamed colonic mucosa Pharm. Res. 18 788 793 doi:10.1023/A:1011032328064
5. A. Lamprecht N. Ubrich H. Yamamoto U. Schäfer H. Takeuchi P. Maincent Y. Kawashima C. M. Lehr 2001 Biodegradable nanoparticles for the targeted drug delivery in the treatment of inflammatory bowel disease J. Pharmacol. Exp. Ther. 299 775 781
6. A. Lamprecht H. Yamamoto H. Takeuchi Y. Kawashima 2005 Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats J. Pharmacol. Exp. Ther. 315 196 202 doi:10.1124/jpet.105.088146
7. R. B. Umamaheshwari S. Ramteke N. K. Jain 2004 Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model AAPS PharmSciTech. 5 E32 doi:10.1208/pt050232
8. K. Dillen C. Bridts P. Van der Veken P. Cos J. Vandervoort K. Augustyns W. Stevens A. Ludwig 2008 Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas Int. J. Pharm. 349 234 240 doi:10.1016/j.ijpharm. 2007.07.041
9. Y. I. Jeong H. S. Na D. H. Seo D. G. Kim H. C. Lee M. K. Jang S. K. Na S. H. Roh S. I. Kim J. W. Nah 2008 Ciprofloxacin-encapsulated poly(DL-lactide-co- glycolide) nanoparticles and its antibacterial activity Int. J. Pharm. 352 317 323 doi:10.1016/j.ijpharm.2007.11.001
10. J. E. Krawisz P. Sharon W. F. Stenson 1984 Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity Gastroenterology 87 1344 1350
11. M. Demoy J. P. Andreux C. Weingarten B. Gouritin V. Guilloux P. Couvreur 1999 Spleen capture of nanoparticles: influence of animal species and surface characteristics Pharm. Res. 16 37 41 doi:10.1023/A:1018858409737
12. S. Okabe K. Amagase 2005 An overview of acetic acid ulcer models-the history and state of the art of peptic ulcer research Biol. Pharm. Bull. 28 1321 1341 doi:10.1248/bpb.28.1321
13. G. P. Morris P. L. Beck M. S. Herridge W. T. Depew M. R. Szewczuk J. L. Wallace 1989 Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroeneterology 96 795 803
14. G. Yue F. F. Sun C. Dunn K. Yin P. Y. K. Wong 1996 The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats J. Pharmacol. Exp. Ther. 276 265 270
15. M. P. Desai V. Labhasetwar G. L. Amidon R. J. Levy 1996 Gastrointestinal uptake of biodegradable microparticles: effects of particle size Pharm. Res. 13 1838 1845 doi:10.1023/A:1016085108889
16. P. U. Jani G. W. Halbert J. Langridge A. T. Florence 1989 The uptake and translocation of latex nanospheres and microspheres after oral administration to rats J. Pharm. Pharmacol. 41 809 821
17. P. U. Jani G. W. Halbert J. Langridge A. T. Florence 1990 Nanoparticle uptake by the ratgastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 42 821 826
18. S. Sakuma R. Sudo N. Suzuki H. Kikuchi M. Akashi M. Hayashi 1999 Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract Int. J. Pharm. 177 161 172 doi:10.1016/S0378-5173(98)00346-9
19. S. K. Lai D. E. O'Hanlon S. Harrold S. T. Man Y. Y. Wang R. Cone J. Hanes 2007 Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. 104 1482 1487 doi:10.1073/pnas.0608611104
20. B. Tirosh A. Rubinstein 1998 Migration of adhesive and nonadhesive particles in the rat intestine under altered mucus secretion conditions J. Pharm. Sci. 87 453 456 doi:10.1021/js9703380
21. R. Nagashima 1981 Mechanisms of action of sulcrafate J. Clin. Gastroenterol. 3 117 127
22. M. Polakovic T. Görner R. Gref E. Dellacherie 1999 Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release J. Control. Release 60 169 177 doi:10.1016/S0168-3659(99)00012-7
23. B. Moulari D. Pertuit Y. Pellequer A. Lamprecht 2008 The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis Biomaterials 29 4554 4560 doi:10.1016/j.biomaterials.2008.08.009
24. D. Pertuit B. Moulari T. Betz A. Nadaradjane D. Neumann L. Ismaïli B. Refouvelet Y. Pellequer A. Lamprecht 2007 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease J. Control. Release 123 211 218 doi:10.1016/j.jconrel.2007.08.008